Welcome to BenefitsPRO weekly roundup! Catch up with some of this week's headlines that we didn't cover.
My personal favorite news bit this week: Ira Pastor, chief executive of Bioquark, a biotech company focused on cellular reprogramming for human cell therapy and tissue regeneration, wants to start the zombie apocalypse. (Well, not really, but if you're like me and zombies are often your chosen conversation starter, keep reading.) Pastor's mission — reanimating brain dead patients — does sound like the beginning of a Frankenstein-esque plot that could take a turn for the worst, but his intent is to change the misconception that brain death is the point of no return. It's true, the mind is a mystery, and many family members of patients, like those of Jahi McMath, agree that irreversible comas don't necessarily signify death. Pastor's proposed study of 20 patients has stirred worries on almost every level, but he says if Bioquark's radical treatment works, the applications can go beyond waking the "dead."
Military personnel are plagued by financial concerns, so much so that a new study says 65 percent of retired military, veterans, reservists, and family members are stressed by their personal finances. Twenty percent of those polled in the Zebit survey say their finances are unstable. Seventeen percent said the state of their financials led to an inability to focus while on duty.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
